These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging. Burke C; Alexander Grant L; Goh V; Griffin N Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317 [TBL] [Abstract][Full Text] [Related]
9. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599 [TBL] [Abstract][Full Text] [Related]
10. Gaucher disease in the liver on hepatocyte specific contrast agent enhanced MR imaging. Ayyala RS; Teot LA; Perez Rossello JM Pediatr Radiol; 2017 Apr; 47(4):484-487. PubMed ID: 28144704 [TBL] [Abstract][Full Text] [Related]
11. Gadolinium contrast agent selection and optimal use for body MR imaging. Guglielmo FF; Mitchell DG; Gupta S Radiol Clin North Am; 2014 Jul; 52(4):637-56. PubMed ID: 24889165 [TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific contrast media: not so simple. Trout AT; Towbin AJ; Smith EA; Gupta A; Dillman JR Pediatr Radiol; 2018 Aug; 48(9):1245-1255. PubMed ID: 30078050 [TBL] [Abstract][Full Text] [Related]
13. Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents. Gupta RT; Brady CM; Lotz J; Boll DT; Merkle EM AJR Am J Roentgenol; 2010 Aug; 195(2):405-13. PubMed ID: 20651197 [TBL] [Abstract][Full Text] [Related]
14. Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America. Mithal LB; Patel PS; Mithal D; Palac HL; Rozenfeld MN Pediatr Radiol; 2017 May; 47(6):657-664. PubMed ID: 28283727 [TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518 [TBL] [Abstract][Full Text] [Related]
16. Use of magnetic resonance imaging contrast agents in the liver and biliary tract. Lebedis C; Luna A; Soto JA Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):715-37. PubMed ID: 23088947 [TBL] [Abstract][Full Text] [Related]
17. Gadolinium based contrast agents (GBCA): Safety overview after 3 decades of clinical experience. Kanal E Magn Reson Imaging; 2016 Dec; 34(10):1341-1345. PubMed ID: 27608608 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance contrast agents for liver imaging. Bashir MR Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):283-93. PubMed ID: 25086930 [TBL] [Abstract][Full Text] [Related]
19. Part 2: MRI of hypervascular focal liver lesions using liver specific contrast agents. Sutherland T; Seale M; Yap K J Med Imaging Radiat Oncol; 2014 Feb; 58(1):56-63. PubMed ID: 24529056 [TBL] [Abstract][Full Text] [Related]
20. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats. Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]